Results 31 to 40 of about 179,002 (365)

Graft-versus-host disease [PDF]

open access: yesJournal of the American Academy of Dermatology, 2012
Approximately 25,000 allogeneic hematopoietic cell transplants are performed worldwide each year for a variety of malignant and non-malignant conditions. Graft-versus-host disease represents one of the most frequent complications and is a major source of long-term morbidity and mortality.
Amin M. Alousi   +2 more
openaire   +8 more sources

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

open access: yesHaematologica, 2011
Background The 2005 National Institutes of Health Consensus Development Conference on chronic graft-versus-host disease proposed major changes in the classification and grading of severity of chronic graft-versus-host disease.Design and Methods We aimed ...
Joseph Pidala   +6 more
doaj   +1 more source

Improved survival after acute graft- [PDF]

open access: yes, 2017
A cute graft- versus -host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted ...
Aljurf, Mahmoud   +45 more
core   +2 more sources

Vitiligo-like manifestations of graft-versus-host disease in a pediatric population [PDF]

open access: yes, 2022
Vitiligo-like changes are an uncommon cutaneous manifestation of graft-versus-host disease (GVHD). We report three cases and review the literature of pediatric patients with vitiligo-like changes associated with GVHD.
Dai, Julia   +4 more
core   +1 more source

Graft versus host disease [PDF]

open access: yesJournal of the American Academy of Dermatology, 1981
Graft versus host disease (GVHD) occurs in 50% to 70% of patients receiving bone marrow transplants. It can also develop in immunosuppressed patients with malignancies who receive nonirradiated blood transfusions. Most work indicates that the primary mechanism of GVHD is cell-mediated. It is likely that humoral factors are involved as well.
openaire   +5 more sources

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

open access: yesHaematologica, 2016
We previously reported that bone marrow grafts from matched sibling donors resulted in best graft-versus-host disease-free, relapse-free survival at 1-year post allogeneic hematopoietic cell transplantation.
Rohtesh S. Mehta   +14 more
doaj   +1 more source

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

open access: yesHaematologica, 2015
Ocular chronic graft-versus-host disease is one of the most bothersome common complications following allogeneic hematopoietic stem cell transplantation.
Lauren M. Curtis   +12 more
doaj   +1 more source

Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms. Graft-versus-host disease is clinically classified as acute or chronic.
Luiza Vasconcelos   +6 more
doaj   +1 more source

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

open access: yesHaematologica, 2016
Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III–IV acute graft-versus-host disease, systemically treated chronic graft-versus-host disease, relapse, and death, is a novel, meaningful composite end point ...
Yoshihiro Inamoto   +16 more
doaj   +1 more source

Forecasting Disease Burden In Philippines: A Symbolic Regression Analysis [PDF]

open access: yesarXiv, 2021
Burden of disease measures the impact of living with illness and injury and dying prematurely and it is increasing worldwide leading cause of death both global and national. This paper aimed to propose an index of diseases and evaluate a mathematical model to describe the number of burden of disease by cause in the Philippines from 1990 - 2016. Through
arxiv  

Home - About - Disclaimer - Privacy